" class="no-js "lang="en-US"> ViiV Healthcare - Medtech Alert
Thursday, March 28, 2024
ViiV Healthcare | Pharmtech Focus

ViiV Healthcare

About ViiV Healthcare

ViiV Healthcare

We are ViiV Healthcare: a global specialist HIV company, 100% focused on researching and delivering new medicines and improving access to care for people living with HIV.

Our global headquarters are in Brentford, London UK; with our US headquarters in Research Triangle Park, North Carolina.

You can read our Social Media Code of Conduct at: bit.ly/SoMe-VHC

Related Story

ViiV Healthcare announces positive data demonstrating long-acting injectable Cabenuva is as effective as daily oral Biktarvy for the treatment of HIV-1

February 23 2023

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi […]

ViiV Healthcare Announces US FDA Approval of Apretude (Cabotegravir Extended-release Injectable Suspension), the First and Only Long-acting Injectable Option for HIV Prevention

December 21 2021

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer […]

ViiV Healthcare New Drug Application for Long-Acting Cabotegravir for Prevention of HIV

May 4 2021

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer […]